Gene therapy: credibility or curse?

Authors

  • Ameena Ahmed Faculty of Pharmaceutical Science, Assam down town University, Sankar Madhab Path, Gandhi Nagar Panikhaiti, Guwahati, Assam 781026
  • Mrinmoy Pratim Chetia Department of Pharmaceutical Technology, University of North Bengal, Raja Rammohunpur, Darjeeling, West Bengal 734013, India
  • Satyabrat Sarma Faculty of Pharmaceutical Science, Assam down town University, Sankar Madhab Path, Gandhi Nagar Panikhaiti, Guwahati, Assam 781026

Keywords:

Gene therapy, strategies, advantages, disadvantages, germline, in vivo, ex vivo

Abstract

Background: Gene therapy is a promising therapeutic approach that involves introducing functional genetic material into defective or diseased cells to treat or prevent disease. Recent advances have led to significant success in managing inherited disorders such as cystic fibrosis, alpha-1 antitrypsin deficiency, hemophilia, beta-thalassemia, and sickle cell disease, and have also shown potential in treating cancers and infectious diseases, including HIV. Several gene therapy products have received regulatory approval for clinical use; however, concerns regarding their long-term efficacy and safety remain. Methodology: This review summarizes the current status of gene therapy by discussing major therapeutic approaches, including ex vivo and in vivo gene delivery, genome editing, somatic gene therapy, and germline gene therapy. It also examines the clinical outcomes of approved gene therapies and evaluates their associated safety challenges. Results and Discussion: Advances in gene therapy have demonstrated encouraging clinical outcomes, particularly for inherited genetic disorders. Somatic gene therapy has shown promising efficacy and an acceptable safety profile in approved clinical applications. In contrast, germline gene therapy still faces substantial technical, ethical, and safety concerns, limiting its clinical translation despite its potential to prevent hereditary diseases. Conclusion: Gene therapy represents a transformative strategy for treating genetic and acquired diseases. While somatic gene therapy has become a viable clinical option, germline gene therapy requires further technological refinement and rigorous safety evaluation before widespread clinical application. Continued research is expected to improve the safety, efficacy, and therapeutic potential of gene-based interventions.

Downloads

Published

2026-11-15

How to Cite

Ahmed, A., Chetia, M. P., & Sarma, S. (2026). Gene therapy: credibility or curse?. Journal of Applied Pharmacognosy and Phytochemistry, 4(2), 17-25. Retrieved from https://joapponline.com/index.php/joapp/article/view/30

Issue

Section

Articles